Cipla Ltd banner

Cipla Ltd
NSE:CIPLA

Watchlist Manager
Cipla Ltd Logo
Cipla Ltd
NSE:CIPLA
Watchlist
Price: 1 341.1 INR -0.53%
Market Cap: ₹1.1T

Profitability Summary

Cipla Ltd's profitability score is 59/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score
59/100
Profitability
Score

Margins

Earnings Waterfall
Cipla Ltd

Margins Comparison
Cipla Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Cipla Ltd
NSE:CIPLA
1.1T INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
986.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
596.5B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
293B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
249.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
240.5B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
305.9B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
156.9B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Cipla Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Cipla Ltd
NSE:CIPLA
1.1T INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
986.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
596.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
293B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
249.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
240.5B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
305.9B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
156.9B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Cipla Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett